candidates for semaglutide GI and Hepatology News Semaglutide Treatment for Weight Loss

There are only a few published cases of semaglutide use in PWS, usually in the setting of concomitant diabetes using doses of 0.5 and 1 mg weekly, with limited evidence on the long-term efficacy and safety of semaglutide in PWS without diabetes

Many protocols are time-based (for example, evening use to match circadian goals) and cycle-based (used for a defined period, then paused)

Rapid weight loss can be associated with reductions in bone mineral density, which is of particular relevance to perimenopausal and postmenopausal women who are already at increased risk of osteoporosis

The mTOR pathway regulates cell growth and metabolism, and inhibiting it mimics the effects of caloric restriction, which has been linked to longevity